Literature DB >> 9375684

Casein kinase 1 is tightly associated with paired-helical filaments isolated from Alzheimer's disease brain.

J Kuret1, G S Johnson, D Cha, E R Christenson, A J DeMaggio, M F Hoekstra.   

Abstract

The protein kinase activity tightly associated with paired helical filaments (PHFs) purified from the brain tissue of individuals with Alzheimer's disease has been characterized in vitro. The activity is shown to phosphorylate casein, an exogenous substrate, with a maximal velocity of approximately 2 nmol/min/mg, suggesting it comprises a significant component of the total protein in the PHF preparation. On the basis of substrate selectivity, isoquinoline sulfonamide inhibitor selectivity, in-gel renaturation assays, and western analysis, the activity consists of closely related members of the alpha branch of the casein kinase 1 family of protein kinases. Because of its tight association with PHFs and its phosphate-directed substrate selectivity, casein kinase 1 is positioned to participate in the pathological hyperphosphorylation of tau protein that is observed in neurodegenerative diseases such as Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375684     DOI: 10.1046/j.1471-4159.1997.69062506.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

1.  Identification of modulators of autophagic flux in an image-based high content siRNA screen.

Authors:  Christopher M Hale; Qingwen Cheng; Danny Ortuno; Ming Huang; Dana Nojima; Paul D Kassner; Songli Wang; Michael M Ollmann; Holly J Carlisle
Journal:  Autophagy       Date:  2016       Impact factor: 16.016

Review 2.  Tau as a therapeutic target for Alzheimer's disease.

Authors:  A Boutajangout; E M Sigurdsson; P K Krishnamurthy
Journal:  Curr Alzheimer Res       Date:  2011-09       Impact factor: 3.498

3.  Protein kinase CK1alphaLS promotes vascular cell proliferation and intimal hyperplasia.

Authors:  Mikhail P Panchenko; Zakir Siddiquee; David M Dombkowski; Yuriy O Alekseyev; Marc E Lenburg; Jennifer D Walker; Thomas E Macgillivray; Frederic I Preffer; James R Stone
Journal:  Am J Pathol       Date:  2010-08-09       Impact factor: 4.307

4.  A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease.

Authors:  N Ghoshal; J F Smiley; A J DeMaggio; M F Hoekstra; E J Cochran; L I Binder; J Kuret
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 5.  Spatiotemporal regulation of the Dma1-mediated mitotic checkpoint coordinates mitosis with cytokinesis.

Authors:  Sierra N Cullati; Kathleen L Gould
Journal:  Curr Genet       Date:  2019-01-02       Impact factor: 3.886

6.  Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors.

Authors:  Feng Liu; David M Virshup; Angus C Nairn; Paul Greengard
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

7.  Small-molecule mediated neuroprotection in an in situ model of tauopathy.

Authors:  Nicolette S Honson; Jordan R Jensen; Aida Abraha; Garth F Hall; Jeff Kuret
Journal:  Neurotox Res       Date:  2009-02-26       Impact factor: 3.911

8.  Analysis of cell type-specific expression of CK1 epsilon in various tissues of young adult BALB/c Mice and in mammary tumors of SV40 T-Ag-transgenic mice.

Authors:  Anja C Utz; Heidrun Hirner; Annette Blatz; Andreas Hillenbrand; Bernhard Schmidt; Wolfgang Deppert; Doris Henne-Bruns; Dietmar Fischer; Dietmar R Thal; Frank Leithäuser; Uwe Knippschild
Journal:  J Histochem Cytochem       Date:  2009-09-15       Impact factor: 2.479

9.  Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis.

Authors:  Theresa J Kannanayakal; Jerry R Mendell; Jeff Kuret
Journal:  Neurosci Lett       Date:  2007-12-15       Impact factor: 3.046

10.  Regulation of protein kinase CK1alphaLS by dephosphorylation in response to hydrogen peroxide.

Authors:  Shahinaz Bedri; Stephanie M Cizek; Iryna Rastarhuyeva; James R Stone
Journal:  Arch Biochem Biophys       Date:  2007-06-21       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.